Search
Selected: All

Methods for producing neutralizing antitoxin to C. difficile...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods for screening for antimicrobials utilizing AarC and comp

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods for stimulating immune responses in a host through the a

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of eliciting an antibody response using flea protease pr

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of eliciting broadly neutralizing antibodies...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of generating a humoral immune response against...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of immunization by administering fibrinogen binding...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of inhibiting angiogenesis and ameliorating cancer...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of inhibiting complement activation

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of inhibiting osteoclastogenesis

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of making antibodies that bind Nogo

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of making antibodies that bind Nogo

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of making recombinant disulfide-stabilized...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of preparation and use for zona pellucida antigens and a

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of reducing bone loss with CD40 ligand

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of treating a tumor that expresses APRIL by...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of treating allergies using TGF-β1 and allergens

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of treatment with antagonists of MU-1

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of use of recombinant vasoactive protein from...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of using poxvirus p35 as a chemokine inhibitor and compo

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.